Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
Annals of Internal Medicine|May 15, 1991
Prognostic value of serum beta-2 microglobulin in low-grade lymphomaP Litam, F Swan, F Cabanillas, et al.
International Journal of Radiation Oncology, Biology, Physics|February 13, 2001
Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapyR B Wilder, S L Tucker, C S Ha, et al.
International Journal of Radiation Oncology, Biology, Physics|June 8, 2001
Radiation therapy after a partial response to CHOP chemotherapy for aggressive lymphomasR B Wilder, M A Rodriguez, S L Tucker, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 1996
Comparison between normal tissue reactions and local tumor control in head and neck cancer patients treated by definitive radiotherapyF B Geara, L J Peters, K K Ang, et al.
International Journal of Cancer|July 20, 2000
Stereotactic radiosurgery for brain metastases: results and prognostic factorsM H Maor, P Dubey, S L Tucker, et al.
Cancer Research|January 15, 1987
Biological effect of epidermal growth factor on the in vitro growth of human tumorsS E Singletary, F L Baker, G Spitzer, et al.
International Journal of Radiation Oncology, Biology, Physics|August 27, 1998
Subdiaphragmatic stage I & II Hodgkin's disease: long-term follow-up and prognostic factorsZ Liao, C S Ha, L M Fuller, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 1, 1994
Radiation-induced injury to the visual pathwayG L Jiang, S L Tucker, R Guttenberger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1986
Tumor burden assessment and its implication for a prognostic model in advanced diffuse large-cell lymphomaS Jagannath, W S Velasquez, S L Tucker, et al.
Human Pathology|June 1, 1996
Prognostic significance of biomarkers (c-erbB-2, p53, proliferating cell nuclear antigen, and DNA content) in salivary duct carcinomaA Felix, A K El-Naggar, M F Press, et al.
Pageof 11